Annual EBITDA
-$54.11 M
+$10.94 M+16.82%
December 31, 2023
Summary
- As of February 7, 2025, MLTX annual EBITDA is -$54.11 million, with the most recent change of +$10.94 million (+16.82%) on December 31, 2023.
- MLTX annual EBITDA is now at all-time high.
Performance
MLTX EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$43.08 M
-$12.53 M-41.01%
September 30, 2024
Summary
- As of February 7, 2025, MLTX quarterly EBITDA is -$43.08 million, with the most recent change of -$12.53 million (-41.01%) on September 30, 2024.
- Over the past year, MLTX quarterly EBITDA has dropped by -$12.53 million (-41.01%).
- MLTX quarterly EBITDA is now -587.63% below its all-time high of -$6.26 million, reached on September 30, 2021.
Performance
MLTX Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$108.45 M
-$30.11 M-38.43%
September 30, 2024
Summary
- As of February 7, 2025, MLTX TTM EBITDA is -$108.45 million, with the most recent change of -$30.11 million (-38.43%) on September 30, 2024.
- Over the past year, MLTX TTM EBITDA has dropped by -$30.11 million (-38.43%).
- MLTX TTM EBITDA is now -231.84% below its all-time high of -$32.68 million, reached on June 30, 2021.
Performance
MLTX TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
MLTX EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +16.8% | -41.0% | -38.4% |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
MLTX EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +16.8% | -233.2% | at low | -172.1% | at low |
| 5 y | 5-year | at high | +16.8% | -587.6% | at low | -231.8% | at low |
| alltime | all time | at high | +16.8% | -587.6% | at low | -231.8% | at low |
MoonLake Immunotherapeutics EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$43.08 M(+41.0%) | -$108.45 M(+38.4%) |
| Jun 2024 | - | -$30.55 M(+54.3%) | -$78.35 M(+28.5%) |
| Mar 2024 | - | -$19.80 M(+31.8%) | -$60.98 M(+12.7%) |
| Dec 2023 | -$54.11 M | -$15.03 M(+15.8%) | -$54.11 M(-3.0%) |
| Sep 2023 | - | -$12.97 M(-1.6%) | -$55.78 M(-3.1%) |
| Jun 2023 | - | -$13.18 M(+2.0%) | -$57.57 M(-7.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2023 | - | -$12.93 M(-22.6%) | -$62.04 M(-4.6%) |
| Dec 2022 | -$65.05 M | -$16.69 M(+13.0%) | -$65.05 M(+34.5%) |
| Sep 2022 | - | -$14.77 M(-16.3%) | -$48.36 M(+21.3%) |
| Jun 2022 | - | -$17.65 M(+10.7%) | -$39.85 M(-27.4%) |
| Mar 2022 | - | -$15.94 M(+154.4%) | -$54.89 M(+40.9%) |
| Sep 2021 | - | -$6.26 M(-80.8%) | -$38.95 M(+19.2%) |
| Jun 2021 | - | -$32.68 M | -$32.68 M |
FAQ
- What is MoonLake Immunotherapeutics annual EBITDA?
- What is the all time high annual EBITDA for MoonLake Immunotherapeutics?
- What is MoonLake Immunotherapeutics annual EBITDA year-on-year change?
- What is MoonLake Immunotherapeutics quarterly EBITDA?
- What is the all time high quarterly EBITDA for MoonLake Immunotherapeutics?
- What is MoonLake Immunotherapeutics quarterly EBITDA year-on-year change?
- What is MoonLake Immunotherapeutics TTM EBITDA?
- What is the all time high TTM EBITDA for MoonLake Immunotherapeutics?
- What is MoonLake Immunotherapeutics TTM EBITDA year-on-year change?
What is MoonLake Immunotherapeutics annual EBITDA?
The current annual EBITDA of MLTX is -$54.11 M
What is the all time high annual EBITDA for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high annual EBITDA is -$54.11 M
What is MoonLake Immunotherapeutics annual EBITDA year-on-year change?
Over the past year, MLTX annual EBITDA has changed by +$10.94 M (+16.82%)
What is MoonLake Immunotherapeutics quarterly EBITDA?
The current quarterly EBITDA of MLTX is -$43.08 M
What is the all time high quarterly EBITDA for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high quarterly EBITDA is -$6.26 M
What is MoonLake Immunotherapeutics quarterly EBITDA year-on-year change?
Over the past year, MLTX quarterly EBITDA has changed by -$12.53 M (-41.01%)
What is MoonLake Immunotherapeutics TTM EBITDA?
The current TTM EBITDA of MLTX is -$108.45 M
What is the all time high TTM EBITDA for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high TTM EBITDA is -$32.68 M
What is MoonLake Immunotherapeutics TTM EBITDA year-on-year change?
Over the past year, MLTX TTM EBITDA has changed by -$30.11 M (-38.43%)